Rosetta Genomics Ltd. Announces Participation In Cantor Fitzgerald’s Inaugural “From Bench To Bedside” Healthcare Conference

PRINCETON, N.J. & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based and other molecular diagnostics, announces that company management will participate at the 2015 Inaugural “From Bench to Bedside” Healthcare Conference hosted by Cantor Fitzgerald. The conference will take place at Le Parker Meridien Hotel in New York City on Wednesday, July 8th. Ken Berlin, President and Chief Executive Officer of Rosetta Genomics, will deliver a corporate overview at 2:00 p.m. Eastern time.

Help employers find you! Check out all the jobs and post your resume.